ARTICLE | Distillery Techniques
Biomarkers
March 28, 2018 3:47 PM UTC
Circulating plasmablast and B cell numbers could help predict the risk of high-grade, immune-related adverse events in melanoma patients treated with anti-CTLA-4/anti-PD-1 antibody combinations. In pe...
BCIQ Company Profiles